Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin L Masters

Showing results (211-220 of 775) with videos related to

Pageof 78
Sort By:
Alzheimer'S Research & Therapy|June 5, 2019
Avoiding methodological bias in studies of amyloid imaging results disclosureCarl Taswell, Cheryl Donohue, Maree T Mastwyk, et al.
The Journal of Biological Chemistry|April 2, 2010
Conservation of a glycine-rich region in the prion protein is required for uptake of prion infectivityChristopher F Harrison, Victoria A Lawson, Bradley M Coleman, et al.
Free Radical Biology & Medicine|February 9, 2010
Zinc induces depletion and aggregation of endogenous TDP-43Aphrodite Caragounis, Katherine Ann Price, Cynthia P W Soon, et al.
Brain Research|May 22, 2002
Alzheimer's disease amyloid beta and prion protein amyloidogenic peptides promote macrophage survival, DNA synthesis and enhanced proliferative response to CSF-1 (M-CSF)John A Hamilton, Genevieve Whitty, Anthony R White, et al.
Journal of Neurochemistry|June 18, 2002
Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque depositionLisa R Fodero, Javier Sáez-Valero, Catriona A McLean, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 12, 2013
Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementiaChristopher C Rowe, Svetlana Pejoska, Rachel S Mulligan, et al.
Biomarkers in Medicine|August 3, 2013
Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytesAlan Rembach, Tim M Ryan, Blaine R Roberts, et al.
JAMA Neurology|July 17, 2013
Unusual clinical and molecular-pathological profile of gerstmann-Sträussler-Scheinker disease associated with a novel PRNP mutation (V176G)Marion Simpson, Vanessa Johanssen, Alison Boyd, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 27, 2017
Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individualsNoelia Fandos, Virginia Pérez-Grijalba, Pedro Pesini, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 12, 2019
Genetic resilience to Alzheimer's disease in APOE ε4 homozygotes: A systematic reviewAamira J Huq, Peter Fransquet, Simon M Laws, et al.
Pageof 78

Showing results (211-220 of 775) with videos related to

Sort By:
Pageof 78
Alzheimer'S Research & Therapy|June 5, 2019
Avoiding methodological bias in studies of amyloid imaging results disclosureCarl Taswell, Cheryl Donohue, Maree T Mastwyk, et al.
The Journal of Biological Chemistry|April 2, 2010
Conservation of a glycine-rich region in the prion protein is required for uptake of prion infectivityChristopher F Harrison, Victoria A Lawson, Bradley M Coleman, et al.
Free Radical Biology & Medicine|February 9, 2010
Zinc induces depletion and aggregation of endogenous TDP-43Aphrodite Caragounis, Katherine Ann Price, Cynthia P W Soon, et al.
Brain Research|May 22, 2002
Alzheimer's disease amyloid beta and prion protein amyloidogenic peptides promote macrophage survival, DNA synthesis and enhanced proliferative response to CSF-1 (M-CSF)John A Hamilton, Genevieve Whitty, Anthony R White, et al.
Journal of Neurochemistry|June 18, 2002
Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque depositionLisa R Fodero, Javier Sáez-Valero, Catriona A McLean, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 12, 2013
Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementiaChristopher C Rowe, Svetlana Pejoska, Rachel S Mulligan, et al.
Biomarkers in Medicine|August 3, 2013
Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytesAlan Rembach, Tim M Ryan, Blaine R Roberts, et al.
JAMA Neurology|July 17, 2013
Unusual clinical and molecular-pathological profile of gerstmann-Sträussler-Scheinker disease associated with a novel PRNP mutation (V176G)Marion Simpson, Vanessa Johanssen, Alison Boyd, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 27, 2017
Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individualsNoelia Fandos, Virginia Pérez-Grijalba, Pedro Pesini, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 12, 2019
Genetic resilience to Alzheimer's disease in APOE ε4 homozygotes: A systematic reviewAamira J Huq, Peter Fransquet, Simon M Laws, et al.
Pageof 78